- Asked by: Liam Kerr, MSP for North East Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 04 August 2026
-
Current Status:
Answered by Maree Todd on 31 August 2026
To ask the Scottish Government what consideration it has given to publishing regular NHS board-level information regarding confirmed measles cases, including hospital admissions and whether infections were imported or locally acquired, as well as information on MMR and MMRV catch-up vaccination activity, where such information can be published without compromising patient confidentiality.
Answer
Public Health Scotland (PHS) publishes national measles case numbers on a weekly basis. Further information is available in the latest Immunisation and Vaccine Preventable Diseases Quarterly Report, which currently covers the period to March 2026. The next quarterly report, covering the period to the end of June 2026, will be published on 1 September 2026. A summary of trends is also provided in the annual publication Protecting the population of Scotland from vaccine preventable diseases: Vaccination and Immunisation Report - Publications - Public Health Scotland.
Scotland continues to experience relatively low levels of measles. While this is welcome, the small number of cases means that publishing more detailed information, such as NHS Board-level case numbers, hospital admissions, or whether infections were imported or locally acquired, could risk identifying individuals. For this reason, such breakdowns are not routinely published.
Information on MMR and MMRV vaccine uptake is published through the PHS Vaccination Surveillance Dashboard. Although uptake remains high in Scotland, there have been long-term declines, consistent with trends seen elsewhere. Work is ongoing at both national and local levels to improve uptake and reduce inequalities. For example, the five-year Scottish Vaccination and Immunisation Programme Framework sets out priorities to improve vaccine uptake and reduce vaccine-preventable disease, while bi-monthly liaison meetings between PHS and NHS Boards provide opportunities to review local data and address operational challenges.
- Asked by: Ross Greer, MSP for West Scotland, Scottish Green Party
-
Date lodged: Friday, 07 August 2026
-
Current Status:
Answered by Maree Todd on 31 August 2026
To ask the Scottish Government what action it plans to take in response to recommendations 29 to 32 of the Session 6 Health, Social Care and Sport Committee's report, ADHD and autism pathways and support, particularly in relation to making it easier for those with a private diagnosis to receive timely, ongoing ADHD treatment on the NHS.
Answer
Improving access to support for people with neurodevelopmental support needs is a priority for this Government.
The Scottish Government is aware that some people who have received a private diagnosis of ADHD experience difficulties accessing medication through the NHS. Shared care was a key issue discussed at the second neurodevelopment summit convened by the Minister for Social Care and Mental Wellbeing and during the Health, Social Care and Sport Committee inquiry. The outcomes of these discussions will inform ongoing work to improve neurodevelopmental support.
We are committed to working with partners to explore options for shared care arrangements and to consider approaches that are proportionate, effective and meet the needs of both patients and clinicians. Guidance on prescribing ADHD medication to adults following a private-sector diagnosis in Scotland was also published by NAIT in April 2022.
Medication is one form of support for people with an ADHD diagnosis. Many people may also benefit from support available through community and education settings, which can be accessed on the basis of need and do not depend on a formal diagnosis.
- Asked by: Liam Kerr, MSP for North East Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 04 August 2026
-
Current Status:
Answered by Maree Todd on 31 August 2026
To ask the Scottish Government, regarding the uptake of the second dose of the MMR vaccine by age five, what assessment it has made of the latest Public Health Scotland data, which indicates uptake rates of 85.0% in Dundee City and 87.1% in Aberdeen City in the year ending 31 March 2026, compared with 89.7% across Scotland and the World Health Organization’s recommended level of at least 95%, and what targeted action it is taking in these areas in response to this data.
Answer
Long-term declines in uptake are seen across immunisations across the UK 4-nations and beyond, with Scotland comparing favourably. The reasons are multifaceted and include attitudinal and behavioural, as well as structural, and are described here: Understanding and Addressing Declines in Childhood Immunisations - Understanding and Addressing Declines in Childhood Immunisations - Publications - Public Health Scotland
Immunisation uptake varies by NHS Board, local authority and a range of demographic factors, including deprivation, ethnicity, sex and urban-rurality, reflecting a range of interrelated demographic, behavioural and structural factors. In January 2026, the second MMR dose was brought forward from 3 years 4 months to 18 months, creating more opportunities for vaccination before school age. Ongoing improvement activity includes implementation of the five-year Scottish Vaccination and Immunisation Programme (SVIP) framework and regular engagement between Public Health Scotland and NHS Boards.
- Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
-
Date lodged: Monday, 03 August 2026
-
Current Status:
Answered by Maree Todd on 31 August 2026
To ask the Scottish Government what assessment it has made of the impact of gambling-related harm on people’s mental health, financial wellbeing and family relationships.
Answer
There is an established body of UK and international evidence showing that gambling-related harm can have significant consequences for mental health, financial wellbeing and family and personal relationships. Gambling-related harms can affect not only people who gamble, but also families and others close to them.
Through funding from the UK Statutory Gambling Levy, the Scottish Government funded several exploratory projects in 2025-26 to help us understand more about the mental health impacts of gambling harms in Scotland’s communities. Key learning from across the range of projects was highlighted in a flash report published by the Health and Social Care Alliance (the ALLIANCE) in May 2026. We have made further funding available in 2026-27 through the Gambling Harms and Mental Health fund, administered by the ALLIANCE, to continue to support mental health focused work and develop this learning.
The UKRI Research Programme on Gambling is investing in a coordinated programme of independent research to strengthen the evidence base on gambling-related harms. Scottish Government will continue to work with partners to understand how to best prevent and treat gambling-related harms based on the available evidence.
- Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
-
Date lodged: Wednesday, 05 August 2026
-
Current Status:
Answered by Maree Todd on 31 August 2026
To ask the Scottish Government, further to the answer to question S6W-43953 by Jenni Minto on 9 March 2026, what processes are in place to assess the impact that the new funding will have on reducing waiting times for gender-affirming care at Glasgow's Sandyford Gender Identity Clinic.
Answer
In 2024, following a commission from the Scottish Government, Public Health Scotland began publishing nationally collated data on waiting times for NHS gender identity services, making Scotland the first country in the UK to publish such data. The third annual instalment of these data was published on 30 June 2026.
These statistics are essential for understanding local progress and variation in the impact of Scottish Government funding, and provide a foundation for ongoing improvement work. While these data demonstrate good progress in some areas in, we recognise that performance is not yet at the level we all want to see, particularly in NHS Greater Glasgow and Clyde.
Scottish Government officials are engaging closely with the leadership of NHS Greater Glasgow and Clyde to ensure that the Board is appropriately supported to improve its service delivery, and we will continue to share best practices and work collaboratively across NHS Scotland to build on improvements to date.
- Asked by: Liam Kerr, MSP for North East Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 04 August 2026
-
Current Status:
Answered by Maree Todd on 31 August 2026
To ask the Scottish Government whether it will work with NHS Tayside and NHS Grampian to publish targeted plans for improving MMR and MMRV vaccination uptake in Dundee City and Aberdeen City, including consideration of direct reminders, evening and weekend appointments, drop-in clinics and community or school-based vaccination opportunities, and, if so, what timescales and improvement targets it will set.
Answer
The Scottish Government is working with Public Health Scotland and NHS Boards, including NHS Tayside and NHS Grampian, to improve childhood vaccination uptake. Nationally, the five-year Scottish Vaccination and Immunisation Programme (SVIP) Framework sets out priorities to increase uptake, reduce inequalities and minimise the burden of vaccine-preventable disease. Public Health Scotland also holds regular liaison meetings with NHS Boards to review local data, share learning and discuss quality improvement activity. Boards continue to implement measures based on local need, including reminder and recall arrangements, flexible appointments and community-based delivery, supported through existing national improvement arrangements.
- Asked by: Julie MacDougall, MSP for Mid Scotland and Fife, Reform UK
-
Date lodged: Monday, 10 August 2026
-
Current Status:
Answered by Angela Constance on 31 August 2026
To ask the Scottish Government how many dedicated mesothelioma nurses are currently employed in Scotland, and whether this number has increased over the past 20 years.
Answer
The information requested on how many dedicated mesothelioma nurses are currently employed in Scotland, and whether this number has increased over the past 20 years is not held centrally.
- Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
-
Date lodged: Monday, 03 August 2026
-
Current Status:
Answered by Maree Todd on 31 August 2026
To ask the Scottish Government whether it will publish a consolidated timetable for implementing the devolved provisions of the Tobacco and Vapes Act 2026, including the extension of the existing retailer register to nicotine products and herbal smoking products from 29 October 2026, the commencement of the related registration offences from 29 April 2027 and any subsequent regulations relating to the retail display of such products.
Answer
The following table sets out the known coming into force dates for relevant provisions in the Tobacco and Vapes Act 2026.
Date | Description |
Royal Assent (29 April 2026) | Definition of tobacco product is commenced - a product consisting wholly or partly of tobacco and intended to be smoked, sniffed, sucked, chewed or consumed in any other way. |
29 October 2026 | Age of sale (18+) introduced for nicotine products (non-medicinal) and herbal smoking products. Requirements for age verification policies and requirements for authorisation for sale of these products by persons under 18 also come into force. |
29 October 2026 | Free distribution and nominal pricing offence comes into force for tobacco products, herbal smoking products, smoking related products, vaping products and nicotine products. It is currently prohibited under section 9 of the Tobacco Advertising and Promotion Act 2002 to give away in the course of a business any product or coupon where the purpose or effect is to promote a tobacco product. The new provision (which will be in section 8A of the Tobacco and Primary Medical Services (Scotland) act 2020) replaces this and extends the scope to cover all the relevant products. |
29 October 2026 | Vending machine prohibition is extended to cover vending machines dispensing herbal smoking products, cigarette papers and nicotine products. |
29 October 2026 | Secondary legislation has been laid by Scottish Ministers to commence the extension of the Tobacco and Vapes Retailer Register to include nicotine products and herbal smoking products. Retailers can register to sell these products from this date. |
1 January 2027 | Generational ban on smoking, which means from 1 January 2027 no one born on or after 1 January 2009 can legally be sold tobacco, cigarette papers or herbal smoking products. |
29 April 2027 | Offences relating to registration in the expanded retailer register come into force. Retailers must register businesses selling nicotine products and herbal smoking products by this date to avoid committing an offence. The requirements already apply to tobacco and vaping product businesses. |
1 June 2027 | Comprehensive ban on the advertising of tobacco products, vaping products, nicotine products, herbal smoking products and cigarette papers will be brought into force by secondary legislation laid by the UK Government. The intention is that this will come into force across the UK from 1 June 2027. |
The four nations Tobacco and Vapes: Packaging, Appearance and Display consultation was launched on 10 July and is open until 2 October. The consultation will be used to support the development of any potential regulations on packaging, appearance and display of relevant products.
Further information on the implementation of the remaining measures contained within the 2026 Act will be shared with Parliament in due course.
- Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
-
Date lodged: Monday, 03 August 2026
-
Current Status:
Answered by Maree Todd on 31 August 2026
To ask the Scottish Government what assessment it has made of the additional staffing, training, systems and financial costs that local authority trading standards services will incur in implementing and enforcing the Tobacco and Vapes Act 2026, and whether it plans to provide dedicated implementation funding or national guidance to support local authorities in meeting those responsibilities.
Answer
The Scottish Government has worked closely with Trading Standards and COSLA during the development of the Tobacco and Vapes Act 2026 (2026 Act) and will continue to do so during its implementation.
All Scottish Statutory Instruments resulting from the 2026 Act will be supported by the appropriate impact assessments as part of our usual policy development process.
Local Authorities have responsibility to ensure local budget decisions deliver local and national priorities including enforcement of existing legislation around sales, illicit tobacco and vapes, and the single use vape ban. The 2026-27 Scottish Budget provides a further real-terms increase in the Local Government Settlement, delivering record funding of almost £15.7 billion, including a quarter of a billion pounds of unrestricted General Revenue Grant.
On 30 July 2026, the Scottish Government published statutory guidance for retailers of tobacco, vaping, nicotine or herbal smoking products on creating an age verification policy for their store, found here: https://www.gov.scot/publications/selling-tobacco-products-vaping-products-nicotine-products-cigarette-papers-herbal-smoking-products-age-verification-guidance-age-verification-policies-retailers/ .
On 11 August the UK Government published UK-wide guidance on implementation of the 2026 Act which covers the following topics:
- Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
-
Date lodged: Monday, 03 August 2026
-
Current Status:
Answered by Maree Todd on 31 August 2026
To ask the Scottish Government, regarding the introduction of Vaping Products Duty and the Vaping Duty Stamps Scheme on 1 October 2026, what discussions it has had with (a) HM Revenue and Customs, (b) Border Force, (c) Police Scotland, (d) Trading Standards Scotland and (e) COSLA regarding arrangements for sharing intelligence on and coordinating enforcement against illicit and non-compliant vaping products.
Answer
The Scottish Government supports strong alliances to tackle the availability of illicit vapes.
Officials meet regularly with the Society of Chief Officers of Trading Standards in Scotland (SCOTSS) alongside HMRC, who work with Border Force, to take action to tackle the import of illicit tobacco and vaping products at the border.
Intelligence is also shared across the 4-nations as part of the Cross Government Vape Enforcement Committee, which is led by the UK Department of Business and Trade and includes representation from HMRC and Trading Standards.
HMRC, Border Force and the NCA are also valued members of Scotland’s Serious Organised Crime Taskforce (SOCT). The SOCT meets every three months to discuss current and emerging threats and agree where action is required by partners to disrupt serious organised crime.
HMRC also sit on the Multi Agency Tasking and Delivery Board (MATDB) based at the Scottish Crime Campus, Gartcosh. As part of the MATDB, HMRC takes part in the intensification periods organised under Operation Machinize which disrupts a range of criminal activity on the high street.